Grazax (grass pollen allery ADULTS) - Allergen immunotherapy
You are here : Home > Formulary Search > Grazax (grass pollen allery ADULTS) - Allergen immunotherapy
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Status 1
Blue
Formulations :
- Oral lyophilisates
Formulary Status :
Associated Icons :
Restrictions / Comments :
Important
RSFT Immunology only. Initiation and at least 1 month supply from specialist team before any request to transfer prescribing to primary care.
Documentation
- No records returned.
PAD Profile
ChemicalSubstance :
Grazax (grass pollen allery ADULTS)
Indication :
Allergen immunotherapy
Group Name :
Keywords :
seasonal allergic hay fever, hayfever, grass pollen extract
Brand Names Include :
Grazax
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Other Indications
Below are listed other indications that Grazax (grass pollen allery ADULTS) is used to treat.
- No records returned.
Other Drugs
Below are listed other drugs that are used to treat Allergen immunotherapy.
Committee Recommendations (2)
The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.
The KSS policy recommendations committee have reviewed their policy recommendation which was made initially in November 2007. The new recommendations were presented to the PCN members and the members noted that the wording of the statement has changed slightly but the recommendation remains the same, in that Grazax within its licensed indication may be considered as a second line treatment option for individuals with severe hay fever in specified patients